C1GALT1 predicts poor prognosis and is a potential therapeutic target in head and neck cancerMei‐Chun Lin, Min‐Chuan Huang|Oncogene|2018Cited by 67
Targeting tumor O‐glycosylation modulates cancer–immune‐cell crosstalk and enhances anti‐<scp>PD</scp>‐1 immunotherapy in head and neck cancerMei‐Chun Lin, Pei‐Jen Lou|Molecular Oncology|2023Cited by 15